Literature DB >> 19486365

Multiple myeloma presenting with an acute bacterial infection.

G N Kalambokis1, L Christou, E V Tsianos.   

Abstract

Increased susceptibility to bacterial infections is a common manifestation of multiple myeloma (MM), arising mainly from a defect in humoral immunity and is associated with major morbidity and mortality. The propensity to infection is increased in the first months after the initial diagnosis and in patients with renal dysfunction. Gram-positive infections, mainly pneumonia from Streptococcus pneumoniae, occur more frequently in patients with untreated disease while Gram-negative infections, mainly of the urinary tract, are more common after chemotherapy. However, an acute bacterial infection is rarely reported as the first manifestation of underlying MM. In this review, we analysed data from 17 such cases reported between 1978 and 2008. Median age was 65.5 years and most patients were females; monoclonal paraprotein was IgG in 92%. In contrast to diagnosed treated or untreated MM, musculoskeletal infections predominated in these early cases (47%) followed by pneumonia (29%). In particular, septic arthritis, mainly of the knee, was the most common infectious complication (35%). Streptococcus pneumoniae was isolated in two-thirds of infections and bacteremia was common (80%). In this early phase, immunodeficiency arised from a decreased synthesis of polyclonal immunoglobulins. White blood cell counts were frequently normal, particularly in musculoskeletal infections. Renal impairment occurred in 67% and correlated with increasing monoclonal paraprotein levels. The outcome was favorable in most cases (79%). MM should be considered in previously asymptomatic middle-aged patients who present with a major acute bacterial infection, without an apparent predisposing factor. In particular, suspicion should be high in cases of septic arthritis and pneumococcaemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486365     DOI: 10.1111/j.1751-553X.2009.01154.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  8 in total

1.  Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study.

Authors:  Charlene M McShane; Liam J Murray; Eric A Engels; Ola Landgren; Lesley A Anderson
Journal:  Int J Cancer       Date:  2013-10-12       Impact factor: 7.396

2.  Acute Mono-Arthritis of the Knee: A Case Report of Infection with Parvimonas Micra and Concomitant Pseudogout.

Authors:  Martijn Dietvorst; Ramon Roerdink; Alexander C A P Leenders; Menno A Kiel; L Paul A Bom
Journal:  J Bone Jt Infect       Date:  2016-10-01

3.  Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma.

Authors:  Chun-Teng Huang; Chia-Jen Liu; Po-Shen Ko; Han-Tsung Liu; Yuan-Bin Yu; Liang-Tsai Hsiao; Jyh-Pyng Gau; Cheng-Hwai Tzeng; Tzeon-Jye Chiou; Jin-Hwang Liu; Muh-Hwa Yang; Ling-Ju Huang; Chun-Yu Liu
Journal:  BMC Infect Dis       Date:  2017-01-06       Impact factor: 3.090

4.  Case Studies and Literature Review of Pneumococcal Septic Arthritis in Adults.

Authors:  Amandine Dernoncourt; Youssef El Samad; Jean Schmidt; Jean Philippe Emond; Charlotte Gouraud; Anne Brocard; Mohamed El Hamri; Claire Plassart; Florence Rousseau; Valéry Salle; Momar Diouf; Emmanuelle Varon; Farida Hamdad
Journal:  Emerg Infect Dis       Date:  2019-10       Impact factor: 6.883

5.  Infections in patients with multiple myeloma treated with conventional chemotherapy: a single-center, 10-year experience in Pakistan.

Authors:  Mohammad Faizan Zahid; Natasha Ali; Myra Nasir; Maria Haider Baig; Mustafa Iftikhar; Syed Usman Bin Mahmood; Arhama Malik; Sara Atif; Mohammad Asim Beg
Journal:  Hematol Transfus Cell Ther       Date:  2019-06-14

6.  More than Meets the Eye: Bacteremic Pneumococcal Pneumonia as the Initial Presentation of Multiple Myeloma.

Authors:  Jonas Jautz; Eliska Potlukova; Franziska Zeeh; Michael Osthoff
Journal:  Am J Case Rep       Date:  2021-01-06

7.  Bacterial infections exacerbate myeloma bone disease.

Authors:  Rui Liu; Yuping Zhong; Rui Chen; Shiyi Chen; Yazhu Huang; Huan Liu
Journal:  J Transl Med       Date:  2022-01-06       Impact factor: 5.531

8.  Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study.

Authors:  Mathilde Bahuaud; Hélène Bodilis; Marion Malphettes; Anaïs Maugard Landre; Caroline Matondo; Didier Bouscary; Frédéric Batteux; Odile Launay; Jean-Paul Fermand
Journal:  Heliyon       Date:  2017-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.